We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Liquid in tube
Product
Advertisement

ioSensory Neurons: Human iPSC-derived Neurons for Reliable Pain Research

Discover ioSensory Neurons, precision reprogrammed human iPSC-derived nociceptors from bit.bio. Don’t settle for non-human in vitro models or long, complex differentiation protocols that require toxic reagents. Start running reliable nociception assays with ioSensory Neurons today.
Successful BLI
Product
Advertisement

Good Data. Rich Insights. More Discoveries.

Label-free biosensor technologies have emerged as a promising approach to identify high-value hits with a strong likelihood of success as a therapeutic. Unlike traditional approaches of drug discovery, they are fast, sensitive, and come with improved success rates towards high-value drug candidates.
Avio MAx
Product
Advertisement

Avio® 220 Max ICP-OES

Designed with sustainability in mind, the Avio® 220 Max is a compact, hybrid simultaneous ICP-OES with multiple waste-reducing technologies.

From the quickest start-up time on the market to reduced argon consumption, the Avio 220 Max is ideal for labs with low-to-medium throughput requirements.
LANEXO® Inventory Manager content piece image
Product
Advertisement

LANEXO® Inventory Manager

The LANEXO® lab inventory manager lets you easily register, track, and monitor all consumables. Upgrade to an ultra-efficient, audit-ready lab.
Reveal More With The PacBio Revio System’s Exceptionally Accurate Long-Read Sequencing content piece image
Product
Advertisement

Reveal More With the PacBio Revio System’s Exceptionally Accurate Long-Read Sequencing

The Revio system adds affordability, high throughput, and ease of use to a foundation of long
reads, exceptional accuracy, and direct methylation detection. Get reads that are tens of
kilobases in length with >Q30 scores and complete phased genomes for <$1,000, all with 50%
fewer consumables.
One - Stop Research Support for CAR - NK Therapy content piece image
Product
Advertisement

One - Stop Research Support for CAR - NK Therapy

CARNK cell therapies are novel therapeutic options developed with the aim to overcome some limitations of CART cell therapies, such as therapy induced side effects.
PrismA ELISA Kit. The Only Commercial ELISA Kit Specifically Designed for Use With MabSelect PrismA™ Resins. content piece image
Product
Advertisement

PrismA ELISA Kit. The Only Commercial ELISA Kit Specifically Designed for Use With MabSelect PrismA™ Resins.

The PrismA ELISA kit is an enzyme-linked immunosorbent assay designed to measure residual ligand leakage when using MabSelect PrismA™ chromatography resin and Fibro™ PrismA chromatography adsorbers. PrismA ELISA kit is the only commercial kit specifically designed for use with MabSelect PrismA™ resins and Fibro™ PrismA adsorbers.
CellCelector Flex – High-Throughput Image-Based Single-Cell Cloning content piece image
Product
Advertisement

CellCelector Flex – High-Throughput Image-Based Single-Cell Cloning

With the CellCelector Flex single cell and colony picking platform, you can now effectively assess and verify your clones before deciding which ones to choose. In less than one week, you will obtain monoclonal, viable, and productive colonies from your pool of single cells. Instead of relying on large quantities of plates to produce a winner you can now use actual data to reliably predict the future of your clones. This saves consumable and media costs, incubator space, and most of all valuable time by avoiding missteps, a second cloning round, and unnecessary procedures
XiltriX Monitoring-as-a-Service: Keeping a Pulse on Lab Operations content piece image
Product
Advertisement

XiltriX Monitoring-as-a-Service: Keeping a Pulse on Lab Operations

As life science monitoring service providers for 30+ years, our team will address all of your equipment, environmental, and facility monitoring needs with 24/7 support to safeguard critical scientific assets.

Xenium In Situ content piece image
Product
Advertisement

Xenium In Situ

Ductal carcinoma in situ (DCIS), cancer cell growth that starts in the milk ducts, is the most common form of breast cancer. However, why some DCIS progress to invasive carcinoma but others remain innocuous is still unclear. In a recent study, three groundbreaking technologies—Chromium Single Cell, Visium Spatial, and Xenium In Situ—were used to achieve a deeper understanding into the biology of a single, breast cancer patient-derived, FFPE tissue block.
Advertisement